Zinc finger nucleases (ZFNs) are customizable nucleases that have been used to alter endogenous genes in Drosophila, plant, and human cells with high efficiencies ranging from 1%-50%. ZFN-induced DNA double- stranded breaks (DSBs) can be repaired by error-prone non-homologous end-joining (NHEJ) or by homologous recombination (HR) with an appropriately designed exogenous """"""""donor template"""""""" to introduce specific mutations near the break. Recent proof-of-principle experiments have shown that ZFNs can also be used to create targeted NHEJ-mediated knockout mutations in zebrafish embryos. These new findings raise important questions about how to make engineered ZFN technology widely available to zebrafish researchers and whether ZFNs can be used to induce highly efficient HR-mediated gene targeting in zebrafish. Long-term goals of the proposed research are to improve the quality and scope of genetic tools available for use in zebrafish and to make customized ZFN technology readily accessible to all zebrafish research laboratories. To accomplish these goals, we are combining the zinc finger engineering and zebrafish expertise of the Joung and Peterson labs, respectively, at Massachusetts General Hospital to propose the following Specific Aims: (1) to engineer and to make publicly available ZFN pairs for 500 different zebrafish genes using a rapid, robust, and highly effective zinc finger engineering method known as OPEN (for Oligomerized Pool Engineering);(2) to develop and validate a faster and simplified version of the OPEN method (OPEN version 2.0) so that it can be used by any interested academic laboratory;and (3) to demonstrate that ZFNs can be used to induce highly efficient HR-based gene targeting in zebrafish and to optimize parameters for this application. Successful completion of these aims will broaden the use and application of ZFNs for genetic studies in zebrafish, an established and important model organism for studying human development and disease.

Public Health Relevance

Zinc finger nucleases (ZFNs) are customizable """"""""molecular scissors"""""""" that can be used to alter specific genes in a variety of organisms including zebrafish. This proposal will seek to enable broad adoption of ZFN technology by the academic zebrafish community and to expand the range of genome modifications that can be performed with ZFNs. Successful completion of the aims of this proposal will improve the quality and scope of genetic tools available for use in zebrafish, an important model organism for studying human development and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM088040-04
Application #
8303297
Study Section
Special Emphasis Panel (ZRG1-BDA-F (50))
Program Officer
Sledjeski, Darren D
Project Start
2009-08-01
Project End
2013-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
4
Fiscal Year
2012
Total Cost
$563,606
Indirect Cost
$245,184
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Kleinstiver, Benjamin P; Pattanayak, Vikram; Prew, Michelle S et al. (2016) High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529:490-5
Rennekamp, Andrew J; Huang, Xi-Ping; Wang, You et al. (2016) σ1 receptor ligands control a switch between passive and active threat responses. Nat Chem Biol 12:552-8
Parant, John M; Yeh, Jing-Ruey Joanna (2016) Approaches to Inactivate Genes in Zebrafish. Adv Exp Med Biol 916:61-86
Hwang, Woong Y; Fu, Yanfang; Reyon, Deepak et al. (2015) Targeted Mutagenesis in Zebrafish Using CRISPR RNA-Guided Nucleases. Methods Mol Biol 1311:317-34
Tsai, Shengdar Q; Zheng, Zongli; Nguyen, Nhu T et al. (2015) GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol 33:187-97
Gjini, Evisa; Mansour, Marc R; Sander, Jeffry D et al. (2015) A zebrafish model of myelodysplastic syndrome produced through tet2 genomic editing. Mol Cell Biol 35:789-804
Wyvekens, Nicolas; Tsai, Shengdar Q; Joung, J Keith (2015) Genome Editing in Human Cells Using CRISPR/Cas Nucleases. Curr Protoc Mol Biol 112:31.3.1-18
Kleinstiver, Benjamin P; Prew, Michelle S; Tsai, Shengdar Q et al. (2015) Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523:481-5
Rahman, Shamim H; Kuehle, Johannes; Reimann, Christian et al. (2015) Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model. PLoS Genet 11:e1005239
Fu, Yanfang; Sander, Jeffry D; Reyon, Deepak et al. (2014) Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32:279-84

Showing the most recent 10 out of 40 publications